NCT00421590View on ClinicalTrials.gov

Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide).

PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

October 31, 2006

Conditions

Health Postmenopausal Women

Interventions

DRUG

SMC021

Trial Locations (1)

Unknown

Novartis Investigative site, Copenhagen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00421590 - Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide). | Biotech Hunter | Biotech Hunter